RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Basgen to Animals

This is a "connection" page, showing publications John Basgen has written about Animals.
Connection Strength

0.274
  1. Basgen JM, Sobin C. Early chronic low-level lead exposure produces glomerular hypertrophy in young C57BL/6J mice. Toxicol Lett. 2014 Feb 10; 225(1):48-56.
    View in: PubMed
    Score: 0.036
  2. Bai XY, Basgen JM. Podocyte number in the maturing rat kidney. Am J Nephrol. 2011; 33(1):91-6.
    View in: PubMed
    Score: 0.029
  3. Basgen JM, Nicholas SB, Mauer M, Rozen S, Nyengaard JR. Comparison of methods for counting cells in the mouse glomerulus. Nephron Exp Nephrol. 2006; 103(4):e139-48.
    View in: PubMed
    Score: 0.021
  4. Reghuvaran AC, Lin Q, Basgen JM, Banu K, Shi H, Vashist A, Pell J, Perinchery S, He JC, Moledina D, Wilson FP, Menon MC. Comparative evaluation of glomerular morphometric techniques reveals differential technical artifacts between focal segmental glomerulosclerosis and normal glomeruli. Physiol Rep. 2023 07; 11(13):e15688.
    View in: PubMed
    Score: 0.017
  5. Meliambro K, Yang Y, de Cos M, Rodriguez Ballestas E, Malkin C, Haydak J, Lee JR, Salem F, Mariani LH, Gordon RE, Basgen JM, Wen HH, Fu J, Azeloglu EU, He JC, Wong JS, Campbell KN. KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression. JCI Insight. 2023 04 10; 8(7).
    View in: PubMed
    Score: 0.017
  6. Banu K, Lin Q, Basgen JM, Planoutene M, Wei C, Reghuvaran AC, Tian X, Shi H, Garzon F, Garzia A, Chun N, Cumpelik A, Santeusanio AD, Zhang W, Das B, Salem F, Li L, Ishibe S, Cantley LG, Kaufman L, Lemley KV, Ni Z, He JC, Murphy B, Menon MC. AMPK mediates regulation of glomerular volume and podocyte survival. JCI Insight. 2021 10 08; 6(19).
    View in: PubMed
    Score: 0.016
  7. Cao A, Li J, Asadi M, Basgen JM, Zhu B, Yi Z, Jiang S, Doke T, El Shamy O, Patel N, Cravedi P, Azeloglu EU, Campbell KN, Menon M, Coca S, Zhang W, Wang H, Zen K, Liu Z, Murphy B, He JC, D'Agati VD, Susztak K, Kaufman L. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity. J Clin Invest. 2021 05 17; 131(10).
    View in: PubMed
    Score: 0.015
  8. Steffes MW, Basgen JM. Evaluation of glomerular lesions in diabetes mellitus. Kidney Int. 2000 Dec; 58(6):2592-3.
    View in: PubMed
    Score: 0.015
  9. Wei C, Banu K, Garzon F, Basgen JM, Philippe N, Yi Z, Liu R, Choudhuri J, Fribourg M, Liu T, Cumpelik A, Wong J, Khan M, Das B, Keung K, Salem F, Campbell KN, Kaufman L, Cravedi P, Zhang W, O'Connell PJ, He JC, Murphy B, Menon MC. SHROOM3-FYN Interaction Regulates Nephrin Phosphorylation and Affects Albuminuria in Allografts. J Am Soc Nephrol. 2018 11; 29(11):2641-2657.
    View in: PubMed
    Score: 0.013
  10. Zhou Y, Castonguay P, Sidhom EH, Clark AR, Dvela-Levitt M, Kim S, Sieber J, Wieder N, Jung JY, Andreeva S, Reichardt J, Dubois F, Hoffmann SC, Basgen JM, Montesinos MS, Weins A, Johnson AC, Lander ES, Garrett MR, Hopkins CR, Greka A. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models. Science. 2017 12 08; 358(6368):1332-1336.
    View in: PubMed
    Score: 0.012
  11. Singh R, Parveen M, Basgen JM, Fazel S, Meshesha MF, Thames EC, Moore B, Martinez L, Howard CB, Vergnes L, Reue K, Pervin S. Increased Expression of Beige/Brown Adipose Markers from Host and Breast Cancer Cells Influence Xenograft Formation in Mice. Mol Cancer Res. 2016 Jan; 14(1):78-92.
    View in: PubMed
    Score: 0.010
  12. Weins A, Wong JS, Basgen JM, Gupta R, Daehn I, Casagrande L, Lessman D, Schwartzman M, Meliambro K, Patrakka J, Shaw A, Tryggvason K, He JC, Nicholas SB, Mundel P, Campbell KN. Dendrin ablation prolongs life span by delaying kidney failure. Am J Pathol. 2015 Aug; 185(8):2143-57.
    View in: PubMed
    Score: 0.010
  13. Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J Am Soc Nephrol. 2016 Jan; 27(1):216-26.
    View in: PubMed
    Score: 0.010
  14. Basgen JM, Steffes MW, Stillman AE, Mauer SM. Estimating glomerular number in situ using magnetic resonance imaging and biopsy. Kidney Int. 1994 Jun; 45(6):1668-72.
    View in: PubMed
    Score: 0.009
  15. Nicholas SB, Basgen JM, Sinha S. Using stereologic techniques for podocyte counting in the mouse: shifting the paradigm. Am J Nephrol. 2011; 33 Suppl 1:1-7.
    View in: PubMed
    Score: 0.008
  16. Basgen JM, Nevins TE, Michael AF. Quantitation of antigen in tissue by immunofluorescence image analysis. J Immunol Methods. 1989 Nov 13; 124(1):77-83.
    View in: PubMed
    Score: 0.007
  17. Peppa M, Brem H, Cai W, Zhang JG, Basgen J, Li Z, Vlassara H, Uribarri J. Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol. 2006; 26(5):430-6.
    View in: PubMed
    Score: 0.005
  18. Nicholas SB, Mauer M, Basgen JM, Aguiniga E, Chon Y. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats. Am J Nephrol. 2004 Sep-Oct; 24(5):549-56.
    View in: PubMed
    Score: 0.005
  19. Nevins TE, Gaston T, Basgen JM. Quantitative indexes of aminonucleoside-induced nephrotic syndrome. Am J Pathol. 1984 Oct; 117(1):30-6.
    View in: PubMed
    Score: 0.005
  20. Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 2002 Mar; 61(3):939-50.
    View in: PubMed
    Score: 0.004
  21. Vasan S, Zhang X, Zhang X, Kapurniotu A, Bernhagen J, Teichberg S, Basgen J, Wagle D, Shih D, Terlecky I, Bucala R, Cerami A, Egan J, Ulrich P. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature. 1996 Jul 18; 382(6588):275-8.
    View in: PubMed
    Score: 0.003
  22. Li YM, Steffes M, Donnelly T, Liu C, Fuh H, Basgen J, Bucala R, Vlassara H. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci U S A. 1996 Apr 30; 93(9):3902-7.
    View in: PubMed
    Score: 0.003
  23. Steffes MW, Vernier RL, Brown DM, Basgen JM, Mauer SM. Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation. Diabetologia. 1982 Oct; 23(4):347-53.
    View in: PubMed
    Score: 0.001
  24. Houser MT, Scheinman JI, Basgen J, Steffes MW, Michael AF. Preservation of mesangium and immunohistochemically defined antigens in glomerular basement membrane isolated by detergent extraction. J Clin Invest. 1982 May; 69(5):1169-75.
    View in: PubMed
    Score: 0.001
  25. Steffes MW, Leffert JD, Basgen JM, Brown DM, Mauer SM. Epithelia cell foot process width in intact and uninephrectomized diabetic and nondiabetic rats. Lab Invest. 1980 Sep; 43(3):225-30.
    View in: PubMed
    Score: 0.001
  26. Steffes MW, Brown DM, Basgen JM, Mauer SM. Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats. Diabetes. 1980 Jul; 29(7):509-15.
    View in: PubMed
    Score: 0.001
  27. Steffes MW, Brown DM, Basgen JM, Matas AJ, Mauer SM. Glomerular basement membrane thickness following islet transplantation in the diabetic rat. Lab Invest. 1979 Aug; 41(2):116-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support